Why it was recalled
Product contains undeclared ingredients, Hydroxypropyl Methylcellulose (HPMC), Titanium Dioxide, Polyethylene Glycol 400 and 800 (PEG), Triacetin
Product description
FP0392, Confidence, Glucosamine Plus, with White Willow Bark & Boswella, 90 Extended Release Tablets, UPC# 8 10891 02253 7
Lot numbers, UPCs & expiration codes
Lot# 010216 Lot# 070816 Lot# 090117 Lot# 100817
Where it was sold
Nationwide
What to do if you have this product
- Compare the brand, size, and lot/UPC codes on your package with the codes above.
- If it matches, don't eat it. Return it to the store for a refund or throw it away.
- Wash surfaces and containers that touched the product.
- If you feel sick after eating it, contact your doctor. In an emergency call 911.
Recall details
- Recall number
- F-1813-2018
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- Jul 26, 2018
- FDA report date
- Aug 22, 2018
- Quantity
- 5,650 bottles in US distribution (total for all products)
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Confidence Inc./Confidence U.S.A. Inc.
Original FDA data
Every field from FDA enforcement report F-1813-2018, exactly as published.
Show all FDA fields
- City
- Port Washington
- State
- NY
- Status
- Terminated
- Country
- United States
- Event ID
- 80620
- Address
- 138 Haven Ave Ste 101
- Code information
- Lot# 010216 Lot# 070816 Lot# 090117 Lot# 100817
- Postal code
- 11050-3924
- Report date
- Aug 22, 2018
- Product type
- Food
- Recall number
- F-1813-2018
- Classification
- Class III
- Recalling firm
- Confidence Inc./Confidence U.S.A. Inc.
- Product quantity
- 5,650 bottles in US distribution (total for all products)
- Termination date
- Oct 22, 2019
- Reason for recall
- Product contains undeclared ingredients, Hydroxypropyl Methylcellulose (HPMC), Titanium Dioxide, Polyethylene Glycol 400 and 800 (PEG), Triacetin
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- FP0392, Confidence, Glucosamine Plus, with White Willow Bark & Boswella, 90 Extended Release Tablets, UPC# 8 10891 02253 7
- Distribution pattern
- Nationwide
- Recall initiation date
- Jul 26, 2018
- Initial firm notification
- Letter
- Center classification date
- Aug 13, 2018